Table S2. 5-year overall survival rates based on percent of positive pathologic lymph nodes in patients in different clinical nodal stages.

% pathologic nodes	Clinical nodal stage
	cN0			cN1			cN2			cN3
	Survival (%)	n		Survival (%)	n		Survival (%)	n		Survival (%)	n
<10%	69.3±4.9	121		66.4±1	3,101		56.2±1.6	1,693		48.3±1.9	1,137
≥10%	18±8.2	30		33.1±2.1	704		30.7±.7	1,124		22.7±1.4	1,492